Nordson Corporation (Nasdaq: NDSN) announces that it has entered into a definitive agreement to acquire Atrion Corporation (Nasdaq: ATRI), a leader in proprietary medical infusion fluid delivery and niche cardiovascular solutions, for $460.00 per share in cash. This reflects a valuation of 15X Atrion’s 2024 full-year estimated EBITDA, inclusive of synergies Nordson expects to generate in the first two years of its ownership. Headquartered in Allen, Texas, Atrion is a manufacturer of proprietary medical products, generating approximately $169 million in annual revenue in 2023. Established in 1944, Atrion supports customers globally through three specialized FDA registered manufacturing facilities located in the United States.
Read the full article: Nordson Corporation Announces Agreement to Acquire Atrion Corporation, a Market Leader in Medical Infusion and Cardiovascular Technologies //
Source: https://www.businesswire.com/news/home/20240527809373/en/Nordson-Corporation-Announces-Agreement-to-Acquire-Atrion-Corporation-a-Market-Leader-in-Medical-Infusion-and-Cardiovascular-Technologies